Stem Cell Therapy Market - 2024-2033
Description
Stem Cell Therapy Market Overview:
The Stem Cell Therapy Market was valued at US$ 16.44 billion in 2024 and is anticipated to reach US$ 45.69 billion by 2033, at a CAGR of 0.127 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Stem Cell Therapy Market.
This report delivers a comprehensive overview of the Stem Cell Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy Market. The Stem Cell Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Stem Cell Therapy Market Scope:
By Therapy Type
• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy
By Cell Source
• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells
• Others
By Therapeutic Application
• Musculoskeletal Disorders
• Neurological Disorders
• Autoimmune Diseases
• Cardiovascular Diseases
• Wounds & Surgeries
• Inflammatory
• Others
Key Players
• Mesoblast Ltd
• Lineage Cell Therapeutics, Inc.
• BlueRock Therapeutics LP
• Orchard Therapeutics plc.
• Vericel Corporation.
• CRISPR Therapeutics AG
• Fate Therapeutics, Inc.
• Novartis AG
• Bristol Myers Squibb (Juno Therapeutics, Inc.)
• Bluebird Bio, Inc.
• MEDIPOST Co., Ltd.
• ANTEROGEN.CO.,LTD.
• CORESTEMCHEMON Inc.
• PHARMICELL Co., Ltd
• JCR Pharmaceuticals Co., Ltd.
Major Highlights
This report delivers a comprehensive overview of the Stem Cell Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy Market. The Stem Cell Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The Stem Cell Therapy Market was valued at US$ 16.44 billion in 2024 and is anticipated to reach US$ 45.69 billion by 2033, at a CAGR of 0.127 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Stem Cell Therapy Market.
This report delivers a comprehensive overview of the Stem Cell Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy Market. The Stem Cell Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Stem Cell Therapy Market Scope:
By Therapy Type
• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy
By Cell Source
• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells
• Others
By Therapeutic Application
• Musculoskeletal Disorders
• Neurological Disorders
• Autoimmune Diseases
• Cardiovascular Diseases
• Wounds & Surgeries
• Inflammatory
• Others
Key Players
• Mesoblast Ltd
• Lineage Cell Therapeutics, Inc.
• BlueRock Therapeutics LP
• Orchard Therapeutics plc.
• Vericel Corporation.
• CRISPR Therapeutics AG
• Fate Therapeutics, Inc.
• Novartis AG
• Bristol Myers Squibb (Juno Therapeutics, Inc.)
• Bluebird Bio, Inc.
• MEDIPOST Co., Ltd.
• ANTEROGEN.CO.,LTD.
• CORESTEMCHEMON Inc.
• PHARMICELL Co., Ltd
• JCR Pharmaceuticals Co., Ltd.
Major Highlights
This report delivers a comprehensive overview of the Stem Cell Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy Market. The Stem Cell Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
220 Pages
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Therapy Type
- 3.2. Snippet by Cell Source
- 3.3. Snippet by Therapeutic Application
- 3.4. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Advancements in Regenerative Medicine
- 4.1.1.2. XX
- 4.1.2. Restraints
- 4.1.2.1. High Treatment Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter’s Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Patent Analysis
- 5.5. Regulatory Analysis
- 5.6. SWOT Analysis
- 5.7. Unmet Needs
- 6. By Therapy Type
- 6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 6.1.2. Market Attractiveness Index, By Therapy Type
- 6.2. Autologous Stem Cell Therapy*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Allogeneic Stem Cell Therapy
- 7. By Cell Source
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 7.1.2. Market Attractiveness Index, By Cell Source
- 7.2. Adipose Tissue-Derived Mesenchymal Stem Cells*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Bone Marrow-Derived Mesenchymal Stem Cells
- 7.4. Cord Blood/Embryonic Stem Cells
- 7.5. Others
- 8. By Therapeutic Application
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 8.1.2. Market Attractiveness Index, By Therapeutic Application
- 8.2. Musculoskeletal Disorders*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Neurological Disorders
- 8.4. Autoimmune Diseases
- 8.5. Cardiovascular Diseases
- 8.6. Wounds & Surgeries
- 8.7. Inflammatory
- 8.8. Others
- 9. By Region
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 9.2.6.1. U.S.
- 9.2.6.2. Canada
- 9.2.6.3. Mexico
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 9.3.6.1. Germany
- 9.3.6.2. U.K.
- 9.3.6.3. France
- 9.3.6.4. Spain
- 9.3.6.5. Italy
- 9.3.6.6. Rest of Europe
- 9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 9.4.6.1. Brazil
- 9.4.6.2. Argentina
- 9.4.6.3. Rest of South America
- 9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 9.5.6.1. China
- 9.5.6.2. India
- 9.5.6.3. Japan
- 9.5.6.4. South Korea
- 9.5.6.5. Rest of Asia-Pacific
- 9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Source
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 10. Competitive Landscape
- 10.1. Competitive Scenario
- 10.2. Market Positioning/Share Analysis
- 10.3. Mergers and Acquisitions Analysis
- 11. Company Profiles
- 11.1. Mesoblast Ltd*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
- 11.1.2.1. Product Description
- 11.1.2.2. Product Key Performance Indicators (KPIs)
- 11.1.2.3. Historic and Forecasted Product Sales
- 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
- 11.1.3.1. Company Revenue
- 11.1.3.2. Geographical Revenue Shares
- 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
- 11.1.4.1. Mergers & Acquisitions
- 11.1.4.2. Key Product Development Activities
- 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
- 11.2. Lineage Cell Therapeutics, Inc.
- 11.3. BlueRock Therapeutics LP
- 11.4. Orchard Therapeutics plc.
- 11.5. Vericel Corporation.
- 11.6. CRISPR Therapeutics AG
- 11.7. Fate Therapeutics, Inc.
- 11.8. Novartis AG
- 11.9. Bristol Myers Squibb (Juno Therapeutics, Inc.)
- 11.10. Bluebird Bio, Inc.
- 11.11. MEDIPOST Co., Ltd.
- 11.12. ANTEROGEN.CO.,LTD.
- 11.13. CORESTEMCHEMON Inc.
- 11.14. PHARMICELL Co., Ltd
- 11.15. JCR Pharmaceuticals Co., Ltd. (*LIST NOT EXHAUSTIVE)
- 12. Appendix
- 12.1. About Us and Services
- 12.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
